16 results
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
24 May 22
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-3.2
ATRS
Antares Pharma, Inc.
24 May 22
Entry into a Material Definitive Agreement
4:22pm
SC14D9C
EX-3.1
ATRS
Antares Pharma, Inc.
13 Apr 22
Written communication relating to third party tender offer
12:30pm
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
13 Apr 22
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
9:21am
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
28 May 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-3
15aierow4 3jf2
19 May 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3
7qte43vtq1a2yq2
15 May 07
Other Events
12:00am
10-K405
EX-3.1
4rldgmth8 ggb4
16 Apr 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.5
n5ba72 aqshlr
16 Apr 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.3
rxdbhvr oq
31 Mar 99
Annual report (delinquent filer disclosure)
12:00am
S-1/A
EX-3.4
ie1wuoo53pl2 e0y
15 Aug 96
IPO registration (amended)
12:00am
S-1/A
EX-3.3
igeygqsafrudh
15 Aug 96
IPO registration (amended)
12:00am
S-1
EX-3.2
owlp6h4rp
24 Jun 96
IPO registration
12:00am
S-1
EX-3.1
7of83 u7l9jf
24 Jun 96
IPO registration
12:00am
- Prev
- 1
- Next